Stockscreener 앱 받기
5.13
6.65%
0.32
시간 외 거래:
5.05
-0.08
-1.56%
전일 마감가:
$4.81
열려 있는:
$5.07
하루 거래량:
796.31K
Relative Volume:
0.60
시가총액:
$634.18M
수익:
-
순이익/손실:
$-242.30M
주가수익비율:
-2.0685
EPS:
-2.48
순현금흐름:
$-192.10M
1주 성능:
-7.90%
1개월 성능:
+20.42%
6개월 성능:
-50.58%
1년 성능:
-32.14%
1일 변동 폭
$5.07
$5.30
1주일 범위
$4.5505
$5.74
52주 변동 폭
$3.72
$12.61
코젠트 바이오사이언시스 Stock (COGT) Company Profile
명칭
Cogent Biosciences Inc
전화
617-945-5576
주소
275 WYMAN STREET, WALTHAM
COGT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COGT
Cogent Biosciences Inc
|
5.13 | 634.18M | 0 | -242.30M | -192.10M | -2.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.37 | 128.45B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.63 | 65.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
560.90 | 40.09B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.19 | 35.67B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
233.25 | 27.44B | 3.81B | -644.79M | -669.77M | -6.24 |
코젠트 바이오사이언시스 Stock (COGT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-12-11 | 다운그레이드 | Needham | Buy → Hold |
| 2024-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-02-08 | 개시 | Citigroup | Buy |
| 2023-12-11 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2023-12-08 | 개시 | JP Morgan | Overweight |
| 2023-04-28 | 개시 | Robert W. Baird | Outperform |
| 2023-03-27 | 재개 | H.C. Wainwright | Buy |
| 2022-12-14 | 개시 | Needham | Buy |
| 2022-06-28 | 개시 | Guggenheim | Buy |
| 2021-10-11 | 개시 | H.C. Wainwright | Buy |
| 2021-06-09 | 재개 | Jefferies | Buy |
| 2020-12-23 | 개시 | Piper Sandler | Overweight |
| 2020-10-14 | 개시 | Ladenburg Thalmann | Buy |
모두보기
코젠트 바이오사이언시스 주식(COGT)의 최신 뉴스
10 Best Low-Priced Biotech Stocks to Buy Now - Insider Monkey
Q2 EPS Estimate for Cogent Biosciences Lifted by Analyst - Defense World
Dimensional Fund Advisors LP Lowers Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Research Analysts Offer Predictions for COGT FY2028 Earnings - Defense World
Robert W. Baird Cuts Cogent Biosciences (NASDAQ:COGT) Price Target to $7.00 - Defense World
Cogent Biosciences (NASDAQ:COGT) Releases Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Stock Surge: Cogent Biosciences Inc (COGT) Closes at 4.70, Marking a -15.62 Increase/Decrease - DWinneX
Cogent Biosciences (COGT) Maintains Neutral Rating Amid PT Adjustment | COGT Stock News - GuruFocus
Cogent Biosciences (COGT) Price Target Reduced by Baird | COGT Stock News - GuruFocus
Cogent Biosciences Advances with Promising Clinical Trials - TipRanks
MetLife Investment Management LLC Has $443,000 Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Invesco Ltd. Sells 455,437 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - Barchart.com
Wedbush Trims Price Target on Cogent Biosciences to $10 From $11, Maintains Neutral Rating - marketscreener.com
Cogent Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Cogent Biosciences Inc (COGT) Q1 2025 Earnings: EPS Misses at -0 - GuruFocus
Cogent Biosciences (COGT) Plans Strategic Data Announcements in 2025 | COGT Stock News - GuruFocus
Cogent Biosciences Reports First Quarter 2025 Financial Results - GlobeNewswire
Form 424B5 Cogent Biosciences, Inc. - StreetInsider
BRIEF-Cogent Biosciences Q1 Income From Operations USD -74.933 Million - TradingView
Cogent Biosciences Gears Up for 3 Major Clinical Trial Readouts in 2025, Maintains Strong $245M Cash Reserve - Stock Titan
Wells Fargo & Company MN Acquires 14,413 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
(COGT) Trading Signals - news.stocktradersdaily.com
Is Cogent Biosciences, Inc. (COGT) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Insider Monkey
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Invesco Ltd. - Defense World
Barclays PLC Has $1.51 Million Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Sees Unusually High Options Volume (NASDAQ:COGT) - Defense World
Cogent Biosciences Inc [COGT] Records 200-Day SMA of $8.76 - knoxdaily.com
JPMorgan Chase & Co. Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Get in on Cogent Biosciences Inc’s (COGT) buy-in window today! - Sete News
Legal & General Group Plc Has $542,000 Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Inc (COGT) Stock: The Story of a 52-Week Stock Range - investchronicle.com
Financial Metrics Check: Cogent Biosciences Inc (COGT)’s Ratios for Trailing Twelve Months - DWinneX
Results from Cogent Biosciences Inc (COGT) show potential - uspostnews.com
Understanding the Risks of Investing in Cogent Biosciences Inc (COGT) - knoxdaily.com
Let’s Jump Into The Cogent Biosciences Inc (NASDAQ: COGT) Stock Forecast - Marketing Sentinel
Renaissance Technologies LLC Makes New Investment in Cogent Biosciences, Inc. (NASDAQ:COGT) - The AM Reporter
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.43 Consensus Target Price from Brokerages - Defense World
Cogent Appoints New Senior Executives to Lead Market Access and Corporate Strategy | COGT Stock News - GuruFocus
Cogent Biosciences Presents Four Posters at the American Associa - GuruFocus
Cogent Biosciences (COGT) Unveils Promising Preclinical Data on Cancer Inhibitors | COGT Stock News - GuruFocus
Cogent Biosciences, Inc. Unveils Preclinical Data from Four Pipeline Programs at AACR 2025 Annual Meeting - Nasdaq
Cogent Biosciences Presents Four Posters at the American - GlobeNewswire
Breakthrough: Cogent's Cancer Drug Achieves 90% Tumor Inhibition, Plus 3 More Pipeline Advances - Stock Titan
Cogent Biosciences Inc [COGT] Records 50-Day SMA of $6.47 - knoxdaily.com
Perhaps timely catching Cogent Biosciences Inc (COGT) would be a good idea - Sete News
Metric Analysis: Cogent Biosciences Inc (COGT)’s Key Ratios in the Limelight - DWinneX
Cogent Biosciences Inc (COGT) did well last session? - uspostnews.com
Cogent Biosciences Inc (COGT) Becoming More Attractive for Investors - knoxdaily.com
(COGT) Technical Data - news.stocktradersdaily.com
Cogent Biosciences (COGT): Among the Most Promising Penny Stocks According to Analysts - Insider Monkey
코젠트 바이오사이언시스 (COGT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.10%
자본화:
|
볼륨(24시간):